Department of Pediatrics, Asahikawa Medical University, Hokkaido, Japan.
Department of Genetic Counseling, Asahikawa Medical University Hospital, Hokkaido, Japan.
J Clin Neuromuscul Dis. 2022 Sep 1;24(1):49-54. doi: 10.1097/CND.0000000000000392.
Myofibrillar myopathy is a clinically and genetically heterogeneous group of muscle disorders characterized by myofibrillar degeneration. Bcl-2-associated athanogene 3 (BAG3)-related myopathy is the rarest form of myofibrillar myopathy. Patients with BAG3-related myopathy present with early-onset and progressive muscle weakness, rigid spine, respiratory insufficiency, and cardiomyopathy. Notably, the heterozygous mutation (Pro209Leu) in BAG3 is commonly associated with rapidly progressive cardiomyopathy in childhood. We describe a male patient with the BAG3 (Pro209Leu) mutation. The patient presented at age 7 years with muscle weakness predominantly in the proximal lower limbs. Histologic findings revealed a mixture of severe neurogenic and myogenic changes. His motor symptoms progressed rapidly in the next decade, becoming wheelchair-dependent by age 17 years; however, at the age of 19 years, cardiomyopathy was not evident. This study reports a case of BAG3-related myopathy without cardiac involvement and further confirmed the wide phenotypic spectrum of BAG3-related myopathy.
肌原纤维肌病是一组临床表现和遗传学上具有异质性的肌肉疾病,其特征为肌原纤维变性。Bcl-2 相关抗凋亡基因 3(BAG3)相关性肌病是肌原纤维肌病中最罕见的类型。BAG3 相关性肌病患者表现为早发性、进行性肌无力、脊柱僵硬、呼吸功能不全和心肌病。值得注意的是,BAG3 中的杂合突变(Pro209Leu)通常与儿童期快速进展性心肌病相关。我们描述了一名携带 BAG3(Pro209Leu)突变的男性患者。该患者 7 岁时出现以近端下肢为主的肌无力。组织学检查发现存在严重的神经源性和肌源性混合改变。他的运动症状在接下来的十年中迅速进展,17 岁时已需依赖轮椅;然而,19 岁时并未出现心肌病。本研究报告了一例无心脏受累的 BAG3 相关性肌病病例,进一步证实了 BAG3 相关性肌病具有广泛的表型谱。